Achieve Life Sciences (ACHV) Competitors $2.16 -0.01 (-0.46%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$2.26 +0.11 (+4.86%) As of 07:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACHV vs. RIGL, VSTM, VNDA, EBS, XOMA, IRWD, CDXS, SGMO, LXRX, and RGLSShould you be buying Achieve Life Sciences stock or one of its competitors? The main competitors of Achieve Life Sciences include Rigel Pharmaceuticals (RIGL), Verastem (VSTM), Vanda Pharmaceuticals (VNDA), Emergent BioSolutions (EBS), XOMA (XOMA), Ironwood Pharmaceuticals (IRWD), Codexis (CDXS), Sangamo Therapeutics (SGMO), Lexicon Pharmaceuticals (LXRX), and Regulus Therapeutics (RGLS). These companies are all part of the "biotechnology" industry. Achieve Life Sciences vs. Rigel Pharmaceuticals Verastem Vanda Pharmaceuticals Emergent BioSolutions XOMA Ironwood Pharmaceuticals Codexis Sangamo Therapeutics Lexicon Pharmaceuticals Regulus Therapeutics Rigel Pharmaceuticals (NASDAQ:RIGL) and Achieve Life Sciences (NASDAQ:ACHV) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation. Do analysts prefer RIGL or ACHV? Rigel Pharmaceuticals currently has a consensus price target of $36.80, suggesting a potential upside of 115.96%. Achieve Life Sciences has a consensus price target of $15.75, suggesting a potential upside of 629.17%. Given Achieve Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe Achieve Life Sciences is more favorable than Rigel Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rigel Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40Achieve Life Sciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 Does the media favor RIGL or ACHV? In the previous week, Rigel Pharmaceuticals had 3 more articles in the media than Achieve Life Sciences. MarketBeat recorded 5 mentions for Rigel Pharmaceuticals and 2 mentions for Achieve Life Sciences. Achieve Life Sciences' average media sentiment score of 1.76 beat Rigel Pharmaceuticals' score of 1.65 indicating that Achieve Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rigel Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Achieve Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has preferable earnings & valuation, RIGL or ACHV? Rigel Pharmaceuticals has higher revenue and earnings than Achieve Life Sciences. Achieve Life Sciences is trading at a lower price-to-earnings ratio than Rigel Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRigel Pharmaceuticals$179.28M1.70-$25.09M$0.9418.13Achieve Life SciencesN/AN/A-$29.82M-$1.23-1.76 Is RIGL or ACHV more profitable? Rigel Pharmaceuticals has a net margin of 2.46% compared to Achieve Life Sciences' net margin of 0.00%. Rigel Pharmaceuticals' return on equity of -14.80% beat Achieve Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Rigel Pharmaceuticals2.46% -14.80% 3.03% Achieve Life Sciences N/A -108.30%-65.20% Do institutionals and insiders hold more shares of RIGL or ACHV? 66.2% of Rigel Pharmaceuticals shares are held by institutional investors. Comparatively, 33.5% of Achieve Life Sciences shares are held by institutional investors. 9.0% of Rigel Pharmaceuticals shares are held by insiders. Comparatively, 2.0% of Achieve Life Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk & volatility, RIGL or ACHV? Rigel Pharmaceuticals has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Achieve Life Sciences has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Does the MarketBeat Community prefer RIGL or ACHV? Rigel Pharmaceuticals received 133 more outperform votes than Achieve Life Sciences when rated by MarketBeat users. However, 70.46% of users gave Achieve Life Sciences an outperform vote while only 68.98% of users gave Rigel Pharmaceuticals an outperform vote. CompanyUnderperformOutperformRigel PharmaceuticalsOutperform Votes46768.98% Underperform Votes21031.02% Achieve Life SciencesOutperform Votes33470.46% Underperform Votes14029.54% SummaryRigel Pharmaceuticals beats Achieve Life Sciences on 11 of the 18 factors compared between the two stocks. Remove Ads Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACHV vs. The Competition Export to ExcelMetricAchieve Life SciencesDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$74.92M$2.32B$5.33B$7.57BDividend YieldN/A0.78%5.11%4.32%P/E Ratio-1.916.1121.7317.81Price / SalesN/A47.32379.2094.61Price / CashN/A15.7538.1534.64Price / Book-30.862.956.464.00Net Income-$29.82M-$65.73M$3.20B$247.23M7 Day Performance0.93%4.76%2.85%1.45%1 Month Performance-21.74%-14.92%-8.55%-6.24%1 Year Performance-50.68%-18.39%10.46%0.60% Achieve Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACHVAchieve Life Sciences2.3967 of 5 stars$2.16-0.5%$15.75+629.2%-51.5%$74.92MN/A-1.9120Positive NewsRIGLRigel Pharmaceuticals2.7689 of 5 stars$17.04-1.2%$36.80+116.0%+48.2%$304.39M$179.28M121.72160News CoverageGap DownVSTMVerastem3.0556 of 5 stars$5.10-1.2%$13.88+172.1%-56.5%$262.58M$10M-1.6050VNDAVanda Pharmaceuticals4.1869 of 5 stars$4.19+1.2%$16.50+293.8%+7.6%$244.34M$198.77M-13.09290News CoverageGap DownEBSEmergent BioSolutions4.3195 of 5 stars$4.43-1.9%$14.33+223.3%+134.1%$240.88M$1.01B-1.082,420Gap UpXOMAXOMA4.4472 of 5 stars$19.23-1.1%$72.00+274.4%-14.5%$230.36M$10.22M-5.5310Gap DownIRWDIronwood Pharmaceuticals4.5731 of 5 stars$1.27-5.2%$8.60+577.2%-90.7%$203.24M$351.41M-42.33220Analyst DowngradeShort Interest ↓Analyst RevisionNews CoverageGap DownCDXSCodexis3.1208 of 5 stars$2.06-3.3%$8.33+304.5%-16.4%$170.64M$59.35M-2.37250Gap DownSGMOSangamo Therapeutics2.1911 of 5 stars$0.71+7.7%$5.17+630.9%+33.0%$158.85M$57.80M-0.94480Gap DownHigh Trading VolumeLXRXLexicon Pharmaceuticals2.8223 of 5 stars$0.52+23.5%$3.67+608.7%-72.6%$127.40M$31.08M-0.69140Analyst ForecastGap DownHigh Trading VolumeRGLSRegulus Therapeutics2.4106 of 5 stars$1.60-5.0%$12.75+696.9%-29.9%$105.99MN/A-1.5030Short Interest ↑ Remove Ads Related Companies and Tools Related Companies RIGL Alternatives VSTM Alternatives VNDA Alternatives EBS Alternatives XOMA Alternatives IRWD Alternatives CDXS Alternatives SGMO Alternatives LXRX Alternatives RGLS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACHV) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACHV Stock Free ACHV Stock Alerts